Reslizumab, CAS [[241473-69-8]]

Produktübersicht

• Artikelname: Reslizumab, CAS [[241473-69-8]]
• Artikelnummer: TGM-T12706
• Hersteller Artikelnummer: T12706
• Alternativnummer: TGM-T12706-1MG,TGM-T12706-5MG,TGM-T12706-10MG,TGM-T12706-25MG,TGM-T12706-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: DCP835 , DCP-835 , Sch55700 , CEP38072 , CEP-38072

Produktbeschreibung

Reslizumab (Sch 55700) is a humanized immunoglobulin G (IgG)4 kappa monoclonal antibody that binds to human interleukin 5, thereby decreasing eosinophil production and survival.Reslizumab improves lung function, induces a decrease in eosinophil production and maturation, and may be used in the study of asthma.

Produkteigenschaften

• Reinheit: 98.10%
• CAS Nummer: [241473-69-8]
• Target-Kategorie: Interleukin|||IL Receptor

Bilder

T12706